Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Cash & Equivalents (QoQ) (2020 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) Cash & Equivalents (QoQ) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.24%
Mar 31, 2026 -13.96%
Dec 31, 2025 50.54%
Sep 30, 2025 -45.44%
Jun 30, 2025 -34.84%
Mar 31, 2025 -44.37%
Dec 31, 2024 -8.87%
Sep 30, 2024 -15.63%
Jun 30, 2024 -13.10%
Mar 31, 2024 -10.98%
Dec 31, 2023 -10.02%
Sep 30, 2023 -5.11%
Jun 30, 2023 -8.32%
Mar 31, 2023 -8.34%
Dec 31, 2022 1.01%
Sep 30, 2022 -5.41%
Jun 30, 2022 -7.76%
Mar 31, 2022 -3.68%
Dec 31, 2021 -10.87%
Sep 30, 2021 637.22%